(Q38181417)

30 August 2017

title

Modulation of angiogenesis by thyroid hormone and hormone analogues: implications for cancer management (English)

1 reference

30 August 2017

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

Hung-Yun Lin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Heng Yuan Tang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Aleck Hercbergs

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Mary K Luidens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Paul J Davis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

publication date

24 January 2014

1 reference

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

page(s)

463-469

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24458693%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10456-014-9418-5

2 June 2020

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Mouse models for studying angiogenesis and lymphangiogenesis in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Insulin-like growth factors promote vasculogenesis in embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Alphavbeta3 integrin associates with activated insulin and PDGFbeta receptors and potentiates the biological activity of PDGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Integrin activation is required for VEGF and FGF receptor protein presence on human microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

VEGF-integrin interplay controls tumor growth and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Blocking αvβ3 integrin by a recombinant RGD disintegrin impairs VEGF signaling in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Ligand binding to integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Estrogen and progesterone receptor expression is not always specific for mammary and gynecologic carcinomas: a tissue microarray and pooled literature review study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Angiopoietins in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Role of hypoxia-inducible factor-1alpha as a cancer therapy target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Assessing the in vivo efficacy of biologic antiangiogenic therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Study of the cellular mechanism of Sunitinib mediated inactivation of activated hepatic stellate cells and its implications in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

L-Thyroxine vs. 3,5,3'-triiodo-L-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Disparate effects of thyroid hormone on actions of epidermal growth factor and transforming growth factor-alpha are mediated by 3',5'-cyclic adenosine 5'-monophosphate-dependent protein kinase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Thyroid hormone-regulated actin polymerization in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

The contributions of integrin affinity and integrin-cytoskeletal engagement in endothelial and smooth muscle cell adhesion to vitronectin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Molecular mechanisms of actions of formulations of the thyroid hormone analogue, tetrac, on the inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Role of CX3CR1 receptor in monocyte/macrophage driven neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Tetraiodothyroacetic acid and its nanoformulation inhibit thyroid hormone stimulation of non-small cell lung cancer cells in vitro and its growth in xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Response of human pancreatic cancer cell xenografts to tetraiodothyroacetic acid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Tetraiodothyroacetic acid and tetraiodothyroacetic acid nanoparticle effectively inhibit the growth of human follicular thyroid cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Vascularity of primary and metastatic renal cell carcinoma specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Combination cancer chemotherapy with one compound: pluripotent bradykinin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Oroxylin A, a classical natural product, shows a novel inhibitory effect on angiogenesis induced by lipopolysaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5

Lipopolysaccharide enhances mouse lung tumorigenesis: a model for inflammation-driven lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10456-014-9418-5